A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Clinical trial NCT02413229 · COMPLETED

Trial details

NCT number: NCT02413229
Sponsor: Sun Pharmaceutical Industries, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2015-04-01
Primary completion: 2015-09-14
Enrollment: 151

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.